XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 26.52

-22.9%

Dec 11 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: aknahow who wrote (15944)	8/8/2002 1:18:45 PM
From: Cacaito	Read Replies (1) of 17367

Nice partner for Europe... Why did not Roche exercise its first right to any Dna drug! or is it that Roche Dna old agreements are not in place anymore !! maybe, after the buyback and re-IPO of Dna the agreement change. How much money does xoma gets from out of the USA sales ! any, small, none ... I do not know is not the big take xoma will get for the USA future sales, but should be some for xoma tech licenses. Serono seems ready to battle Biogen in many fields, not bad, Blue likes competition a lot! Regarding, the optionetics "reason" for the put season, it is beyond my scope to analized optionetics behavior. BUT, they could not be expert in a lot of things but their option stuff, and technical traders (and analizers)are pretty much off base when it comes to biotech, I have follow several and they have no clue (neither their technicals) about Fda decisions (or clinical results) impact on their technicals. The optionetics "reason" is beyond my season(ing)!!!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next